Alpa P. Shah, M.D.
Pulmonary Disease Physician · Scottsdale, AZ
Alpa P. Shah, M.D. is a pulmonary disease physician with a practice address in Scottsdale, Arizona, and NPI 1881736973, issued on Feb 13, 2007. Check the license (Arizona 35623, as entered in NPPES) on the Arizona Medical Board; the Medicare figures below come from public CMS files.
- Name
- Alpa P. Shah
- Credential
- M.D.
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 35623 AZ
Self-reported in NPPES; status is on the state search - Practice location
- 7301 E 2ND St Ste 315, Scottsdale, AZ 85251
- Phone
- (480) 994-9838
- Enumerated
- Feb 13, 2007
- Record last updated
- May 31, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (480) 994-5811
- Medicare enrollment
- Enrolled (PECOS I20070614000067); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 285 in Arizona → Look up another NPI →
Also registered at 7301 E 2ND St Ste 315
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Mily Sheth, MDPulmonary Disease Physician1134481989
Verify Alpa P. Shah in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersArizona Medical Board
Search for license 35623Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
6% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
1,335 Medicare Part D claims for 283 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 59% of claims.
Most prescribed
- Trelegy Ellipta312 claims
- Albuterol Sulfate Hfa142 claims
- Breo Ellipta124 claims
- Prednisone114 claims
- Roflumilast64 claims
- Montelukast Sodium59 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $401.36
9 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Scottsdale Pulmonary And Critical Care LLCScottsdale, AZ
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Alpa P. Shah among 285 pulmonary disease physician records in Arizona
Alpa P. Shah, M.D. is one of 285 pulmonary disease physician records with a practice address in Arizona. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 54% of them.
- NPI issued2007 · 54% of these records are older, 33% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 71% of these records are
- Graduated1999 · median 1998 among the 202 with a school on file
- Record last updated2018 · 48% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Arizona practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Arizona
There are 285 pulmonary disease physician records in Arizona.
All 285 in Arizona → Every provider in Scottsdale → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Mily Sheth, MDScottsdale, AZ 852511134481989
- Farid Ghebleh, MDParadise Valley, AZ 852531992746408
- Cristian Jivcu, M.D.Paradise Valley, AZ 852531033315601
- Emad Kaldawi, M.D.Scottsdale, AZ 852551639144850
- Aamir Awan, M.D.Scottsdale, AZ 852581891733192
- Christopher Beaty, MDScottsdale, AZ 852581235135575
- Cash Beechler, M.D.Scottsdale, AZ 852581477568889
- James Forseth, M.D.Scottsdale, AZ 852581750323416
Common questions
What is Alpa P. Shah, M.D.'s NPI number?
Alpa P. Shah, M.D.'s National Provider Identifier (NPI) is 1881736973, issued on Feb 13, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Alpa P. Shah, M.D. located?
The NPPES record lists a practice address at 7301 E 2ND St Ste 315, Scottsdale, AZ, 85251. Phone: (480) 994-9838. Providers update this record themselves, so call before visiting.
How can I verify Alpa P. Shah, M.D.'s license?
NPPES lists Arizona license number 35623, as entered by the provider. Search the Arizona Medical Board at https://www.azmd.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Alpa P. Shah, M.D. prescribe under Medicare Part D?
In 2024, Alpa P. Shah, M.D. had 1,335 Medicare Part D claims for 283 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.